Skip to main content Scroll Top
Brain photobiomodulation: a potential treatment in Alzheimer’s and Parkinson’s diseases
Most Viewed Posts
Clear Filters
Alzheimer’s disease: REGEnLIFE accelerates its Light4Life clinical trial with the opening of a new trial site at Lyon University Hospital, Hôpital des Charpennes
Alzheimer’s disease: REGEnLIFE accelerates its Light4Life clinical trial with the opening of a new trial site at Lyon University Hospital, Hôpital des Charpennes
1 April 2026
REGEnLIFE cures inflammatory brain diseases with light
REGEnLIFE cures inflammatory brain diseases with light
21 February 2025
Photobiomodulation: light to treat Alzheimer’s disease
Photobiomodulation: light to treat Alzheimer’s disease
2 July 2024
25 April 2025

Brain photobiomodulation: a potential treatment in Alzheimer’s and Parkinson’s diseases

Read the article
JPAD Journal of Prevention of Alzheimer's Disease

Blivet G, Touchon B, Cavadore H, Guillemin S, Pain F, Weiner M, Sabbagh M, Moro C, Touchon J.

J Prev Alzheimers Dis. 2025 Apr 25:100185. doi: 10.1016/j.tjpad.2025.100185. Online ahead of print.

PMID: 40287365 Free article. Review.

Share this article